Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Idera Pharmaceuticals stock

Learn how to easily invest in Idera Pharmaceuticals stock.

Idera Pharmaceuticals is a biotechnology business based in the US. Idera Pharmaceuticals shares (IDRA) are listed on the NASDAQ and all prices are listed in US Dollars. Idera Pharmaceuticals employs 13 staff and has a trailing 12-month revenue of around $49,000.

How to buy Idera Pharmaceuticals stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – IDRA. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance



  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Idera Pharmaceuticals stock price (NASDAQ: IDRA)

Use our graph to track the performance of IDRA stocks over time.

Idera Pharmaceuticals shares at a glance

Information last updated 2023-01-26.
Latest market close$7.23
52-week range$0.22 - $9.52
50-day moving average $6.20
200-day moving average $7.34
Wall St. target price$1.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.44

Buy Idera Pharmaceuticals stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Idera Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Idera Pharmaceuticals price performance over time

Historical closes compared with the close of $7.225 from 2023-01-17

1 week (2023-01-20) 38.68%
1 month (2022-12-27) 3,041.30%
3 months (2022-10-27) 1,752.56%
6 months (2022-07-27) 1,653.64%
1 year (2022-01-27) 1,211.25%
2 years (2021-01-27) 33.55%
3 years (2020-01-27) 308.19%
5 years (2018-01-26) 285.97%

Idera Pharmaceuticals financials

Revenue TTM $49,000
Gross profit TTM $-9,247,000
Return on assets TTM -15.19%
Return on equity TTM -32.32%
Profit margin 0%
Book value $0.35
Market capitalisation $26.5 million

TTM: trailing 12 months

Idera Pharmaceuticals share dividends

We're not expecting Idera Pharmaceuticals to pay a dividend over the next 12 months.

Have Idera Pharmaceuticals's shares ever split?

Idera Pharmaceuticals's shares were split on a 1:17 basis on 17 January 2023. So if you had owned 17 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Idera Pharmaceuticals shares – just the quantity. However, indirectly, the new 1600% higher share price could have impacted the market appetite for Idera Pharmaceuticals shares which in turn could have impacted Idera Pharmaceuticals's share price.

Idera Pharmaceuticals share price volatility

Over the last 12 months, Idera Pharmaceuticals's shares have ranged in value from as little as $0.215 up to $9.5209. A popular way to gauge a stock's volatility is its "beta".

IDRA.US volatility(beta: 1.3)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Idera Pharmaceuticals's is 1.2979. This would suggest that Idera Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Idera Pharmaceuticals overview

Idera Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania. .

Frequently asked questions

What percentage of Idera Pharmaceuticals is owned by insiders or institutions?
Currently 29.559% of Idera Pharmaceuticals shares are held by insiders and 5.522% by institutions.
How many people work for Idera Pharmaceuticals?
Latest data suggests 13 work at Idera Pharmaceuticals.
When does the fiscal year end for Idera Pharmaceuticals?
Idera Pharmaceuticals's fiscal year ends in December.
Where is Idera Pharmaceuticals based?
Idera Pharmaceuticals's address is: 505 Eagleview Boulevard, Exton, PA, United States, 19341
What is Idera Pharmaceuticals's ISIN number?
Idera Pharmaceuticals's international securities identification number is: US45168K4058
What is Idera Pharmaceuticals's CUSIP number?
Idera Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 44860M108

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site